Ensuring rapid and equitable access to effective oral COVID-19 therapies is essential to reducing health disparities from COVID-19 and building a better response system for future epidemics and pandemics. A multipronged strategy for medical countermeasures must include antivirals, monoclonal antibodies, and other mechanisms to fight infections. Better strategies to deploy oral antivirals, which have been important in the context of COVID-19, will also help to prepare the system to deploy medical countermeasures at a large scale in future outbreaks.
In a recent study published in the journal JAMA Network, researchers in the United States investigated factors that restricted the use of antivirals directed at severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the United States (US) between January and February 2022.
The OptumServe testing sites in Klamath, Smith River and Crescent City will be expanding their services to include Test to Treat services starting May 16. Test to Treat services include